Clinical Trials
3 trialsINDUSTRY × Mesothelioma, Malignant × tumor necrosis factor-alpha, CNGRC fusion protein, human × Clear all
NCT01098266 2019-09-17
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
AGC Biologics S.p.A.
Phase 3 Completed
NCT00484276 2019-01-16
NGR010
AGC Biologics S.p.A.
Phase 2 Completed
NCT01358084 2019-01-15
NGR019
AGC Biologics S.p.A.
Phase 2 Completed